NIH-funded research NIH-funded research

Understanding how mouse models relate to human benign prostate hyperplasia

Official title: Validating Mouse Models of Prostatic Hyperplasia

Funded at Endeavor Health Clinical Operations · NIH-11145116 · Data updated 2026-11-12

This study is looking at specially designed mice to help us learn more about benign prostatic hyperplasia (BPH) in people, so we can find better treatments for the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionEndeavor Health Clinical Operations
NIH-funded
Lab location1 site (Evanston, United States)
Project startAugust 1, 2024
Project endMay 31, 2027
Funding year2025
Award (this year)$388,010
NIH project number5P20DK140417-02
Project IDNIH-11145116 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from benign prostatic hyperplasia or related urinary symptoms.

Less likely to help

Patients with prostate cancer or other unrelated urological conditions may not benefit from this research.

What this research studies

This research focuses on validating genetically engineered mouse models to better understand benign prostatic hyperplasia (BPH) in humans. The project aims to correlate transcriptomic data from these mouse models with existing human datasets to identify similarities and differences. By doing so, the researchers hope to improve the relevance of animal models in biomedical research, which is crucial for developing effective treatments for BPH. The work will involve collaboration among biologists and a bioinformatician to create a comprehensive reference database.

Why it matters

Potential benefit: If successful, this research could lead to more accurate animal models that enhance the development of effective treatments for benign prostatic hyperplasia.

How similar studies have gone: Previous research has shown that improving the relevance of animal models can significantly enhance the understanding and treatment of various diseases, making this approach promising.

Where this research is happening

  • Endeavor Health Clinical Operations
    Evanston, United States
    Active

Researchers

  • Principal investigator: Hayward, Simon W — Endeavor Health Clinical Operations
  • Study coordinator: Hayward, Simon W

Related research

Other NIH-funded projects on the same topics.

  • Enhanced MRI to detect brain metastases

    This project uses a new contrast MRI method to make very small brain metastases and leptomeningeal disease easier to see in adults with cancer.

    NIH research Endeavor Health Clinical Operations · Evanston, United States · NIH-11370115

  • Understanding how families’ circumstances affect a child’s language and thinking development

    This project looks at how a child’s early environment and SES shapes language and cognitive development through biological and psychological pathways.

    NIH research Endeavor Health Clinical Operations · Evanston, United States · NIH-11362652

  • TNF blockers and enlarged prostate in aging men

    A study explores whether blocking TNF can help reduce symptoms and enlargement of the prostate in men with BPH/LUTS.

    NIH research Endeavor Health Clinical Operations · Evanston, United States · NIH-11354004

  • Why menstrual pain becomes chronic pelvic pain

    We will follow young women with menstrual pain, including those with bladder sensitivity, to learn who develops ongoing pelvic pain and which early signs predict it.

    NIH research Endeavor Health Clinical Operations · Evanston, United States · NIH-11349686

  • Fat-rich TREM2+ immune cells that may drive an enlarged prostate

    This project looks at whether fat-filled immune cells called TREM2+ macrophages cause prostate enlargement and if targeting them could help men with BPH.

    NIH research Endeavor Health Clinical Operations · Evanston, United States · NIH-11339278

  • How cholesterol and tiny fat droplets affect brain cells in Alzheimer's

    This project explores whether abnormal cholesterol and small fat droplets inside nerve cells harm people with Alzheimer's or those at higher genetic risk (for example, APOE4 carriers) and whether targeting these problems could protect the brain.

    NIH research Endeavor Health Clinical Operations · Evanston, United States · NIH-11306596

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.